HOPO: A potential chelator for use in 44Sc and 47Sc based theranostic agents

被引：0
|
作者：
Phipps, Michael [1 ]
Sanders, Vanessa [2 ]
Younes, Ali [3 ]
Medvedev, Dmitri [2 ]
Lewis, Jason [4 ]
Cutler, Cathy [2 ]
Francesconi, Lynn [3 ]
Deri, Melissa [5 ]
机构：
[1] CUNY, Grad Ctr, New York, NY USA
[2] Brookhaven Natl Lab, Upton, NY 11973 USA
[3] Hunter Coll, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] CUNY, Lehman Coll, New York, NY USA
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2019年 / 62卷
关键词：
COMPLEXES;
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
P-145
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 45 条
  • [21] 44Sc: An Attractive Isotope for Peptide-Based PET Imaging
    Hernandez, Reinier
    Valdovinos, Hector F.
    Yang, Yunan
    Chakravarty, Rubel
    Hong, Hao
    Barnhart, Todd E.
    Cai, Weibo
    MOLECULAR PHARMACEUTICS, 2014, 11 (08) : 2954 - 2961
  • [22] Evaluation of tin dioxide as an inorganic-based stationary phase for a potential 44Ti/44Sc generator
    Deri, Melissa
    Schmidt, Christine
    Shusterman, Jennifer
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S43 - S43
  • [23] Evaluation of the cyclotron production of the positron emitters 43 Sc, 44g Sc and beta emitter 47 Sc radionuclides: An emerging theranostic pair
    Akhtar, S.
    Amjed, N.
    Abrar, M.
    Naz, A.
    Wajid, A. M.
    Hussain, J.
    Ahmad, I.
    RADIATION PHYSICS AND CHEMISTRY, 2024, 221
  • [24] Development of a SnO2-based 44Ti/44Sc generator for medical applications
    Schmidt, Christine E.
    Groveman, Sam
    Sanders, Vanessa A.
    Cutler, Cathy S.
    Shusterman, Jennifer A.
    Deri, Melissa. A.
    JOURNAL OF CHROMATOGRAPHY A, 2024, 1732
  • [25] Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations
    Siwowska, Klaudia
    Guzik, Patrycja
    Domnanich, Katharina A.
    Rodriguez, Josep M. Monne
    Bernhardt, Peter
    Ponsard, Bernard
    Hasler, Roger
    Borgna, Francesca
    Schibli, Roger
    Koster, Ulli
    van der Meulen, Nicholas P.
    Mueller, Cristina
    PHARMACEUTICS, 2019, 11 (08)
  • [26] Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations
    Siwowska, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S163 - S163
  • [27] Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O6-C4, for 43Sc/47Sc, 68Ga, and 45Ti radiopharmaceuticals
    Carbo-Bague, Imma
    Saini, Shefali
    Cingoranelli, Shelbie J.
    Davey, Patrick R. W. J.
    Tosato, Marianna
    Lapi, Suzanne E.
    Ramogida, Caterina F.
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 128
  • [28] Exploring the theranostic potential of 43ScPSMA-617 and 47Sc-PSMA-617
    Cingoranelli, Shelbie
    Tekin, Volkan
    Houson, Hailey
    Putnam, Emily
    Lapi, Suzanne
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [29] Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48Ti Targets for the Production of Theranostic 47Sc Radionuclide, 46cSc, 44mSc, 44gSc, 43Sc, and 48V
    Mou, Liliana
    De Dominicis, Lucia
    Cisternino, Sara
    Skliarova, Hanna
    Campostrini, Matteo
    Rigato, Valentino
    De Nardo, Laura
    Melendez-Alafort, Laura
    Esposito, Juan
    Haddad, Ferid
    Pupillo, Gaia
    PHARMACEUTICALS, 2024, 17 (01)
  • [30] Development of purification of no-carrier-added 47Sc of theranostic interest: selective separation study from the natTi(n,p) process
    Rizk, Hoda E.
    Breky, Mohamed M. E.
    Attallah, Mohamed F.
    RADIOCHIMICA ACTA, 2023, 111 (04) : 273 - 282
12345